Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and Safety Results of INFRONT-3: A Phase 3 Randomized, Double-Blind, Placebo Controlled Study Evaluating Latozinemab (AL001) in FTD-GRN
Aging, Dementia, and Behavioral Neurology
LS2 - Late-breaking Science 2 (5:51 PM-5:57 PM)
002
Authors/Disclosures
ARTHUR J. MAYORGA, PhD
PRESENTER
Dr. MAYORGA has received personal compensation for serving as an employee of Alector, Inc.. Dr. MAYORGA has or had stock in Alector.
Bradley F. Boeve, MD, FAAN (Mayo Clinic) Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Isabelle Le Ber, MD, PhD (AP HP) Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Therapeutics. Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector.
Barbara Borroni, MD Dr. Borroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Borroni has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Catherine Mummery, PhD Dr. Mummery has nothing to disclose.
Jonathan D. Rohrer (Dementia Research Centre) Dr. Rohrer has nothing to disclose.
Giovanna Zamboni, MD (University of Modena and Reggio Emilia) Dr. Zamboni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eli Lilly . The institution of Dr. Zamboni has received research support from European Research Council.
Oezguer A. Onur, MD Prof. Onur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Prof. Onur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Onur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GE.
James Rowe, BA BM BCh PhD James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SV Health. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astex. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Asceneuron. James Rowe, BA BM BCh PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of James Rowe, BA BM BCh PhD has received research support from Janssen. The institution of James Rowe, BA BM BCh PhD has received research support from Lilly. The institution of James Rowe, BA BM BCh PhD has received research support from AZ Medimmune. James Rowe, BA BM BCh PhD has received publishing royalties from a publication relating to health care.
Adam L. Boxer, MD, PhD (University of California, San Francisco) An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Tina Schwabe, PhD Dr. Schwabe has received personal compensation for serving as an employee of Nine Square Therapeutics. Dr. Schwabe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MarinerBio Consulting LLC. Dr. Schwabe has or had stock in Alector.
Olga Kahn, PhD Dr. Kahn has received personal compensation for serving as an employee of Alector. Dr. Kahn has or had stock in Alector .
Julie Huang, PhD (Alector) Dr. Huang has received personal compensation for serving as an employee of Alector, Inc. Dr. Huang has stock in Alector.
Ruchi Gupta, PhD Dr. Gupta has nothing to disclose.
Jinglin Zhong, PhD Ms. Zhong has received personal compensation for serving as an employee of Alector.
Caiyan Li, PhD Dr. Li has nothing to disclose.
Leonardo Guizzetti, PhD The institution of Dr. Guizzetti has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Everest Clinical Research.
Lawrence P. Carter, PhD (Alector) Dr. Carter has received personal compensation for serving as an employee of Alector. Dr. Carter has stock in Alector. Dr. Carter has stock in Jazz Pharmaceuticals.
Tuan S. Nguyen, PhD Mr. Nguyen has received personal compensation for serving as an employee of Alector.
Adam D. Simmons, MD (Alector) Dr. Simmons has received personal compensation for serving as an employee of Alector. Dr. Simmons has or had stock in AstraZeneca.
Tiffany W. Chow, MD, FAAN (Alector) Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.
Balasubrahmanyam Budda, PhD (Alector, Inc) Dr. Budda has received personal compensation for serving as an employee of Alector. Dr. Budda has received personal compensation for serving as an employee of Acceleron Pharma. Dr. Budda has stock in Alector. Dr. Budda has stock in Acceleron Pharma.
Lovingly Q. Park, PhD (UC Davis Medical Center-neurology) Dr. Park has received personal compensation for serving as an employee of Eli Lilly. Dr. Park has received personal compensation for serving as an employee of Alector. Dr. Park has received personal compensation for serving as an employee of Supernus . Dr. Park has received personal compensation for serving as an employee of Parexel .
Sam Jackson, MD Dr. Jackson has received personal compensation for serving as an employee of Neuron23. Dr. Jackson has received personal compensation for serving as an employee of Aditum Bio . Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aerska Biotech. Dr. Jackson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autonomy Bio. Dr. Jackson has received intellectual property interests from a discovery or technology relating to health care.
Robert Paul, MD, PhD Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
Gary J. Romano, MD, PhD (Neurotherapeutic Development Advisors, LLC) Dr. Romano has received personal compensation for serving as an employee of Alector. Dr. Romano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALector. Dr. Romano has or had stock in Alector.
Sara Kenkare-Mitra, PhD Dr. Kenkare-Mitra has received personal compensation for serving as an employee of Alector, Inc..
Arnon Rosenthal, PhD Dr. Rosenthal has received personal compensation for serving as an employee of Alector. Dr. Rosenthal has or had stock in Alector.
Giacomo Salvadore, MD Dr. Salvadore has received personal compensation for serving as an employee of Alector, Inc. Dr. Salvadore has stock in Alector, Inc..